Lacosamide in Refractory Mixed Pediatric Epilepsy: A Prospective Add-on Study
Authors:
- 30 March 2012
- journal article
- research article
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 27 (4) , 492-495
Abstract
Lacosamide is a new antiepileptic drug that is currently approved by the US Food and Drug Administration (FDA) for adults 17 years or older for partial-onset seizures. The authors reviewed 21 pediatric patients (<17 years) with various seizure types who were started on oral lacosamide as part of a prospective add-on study as adjunctive therapy for refractory epilepsy. Five patients were excluded due to less than 3 months of meaningful follow-up. Maintenance dosages used ranged from 2.4 to 19.4 mg/kg/d. Eight of 16 (50%) patients had greater than 50% reduction in seizure frequency with adjunctive lacosamide therapy. Eight (50%) patients had generalized epilepsy including 4 with Lennox-Gastaut syndrome. Lacosamide was effective therapy for most seizure types but was particularly effective for partial-onset seizures. Lacosamide was effective in treating 5 of 8 (62.5%) localization-related epilepsies but only 2 of 8 (25%) generalized epilepsies, both Lennox-Gastaut syndrome patients with greater than 90% seizure reduction. None of these very refractory patients remained seizure free.Keywords
This publication has 9 references indexed in Scilit:
- Lacosamide for the Treatment of Refractory Status EpilepticusAnnals of Pharmacotherapy, 2011
- Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticusSeizure: European Journal of Epilepsy, 2011
- Successful treatment of childhood prolonged refractory status epilepticus with lacosamideSeizure: European Journal of Epilepsy, 2011
- Intravenous lacosamide in status epilepticus and seizure clustersEpilepsia, 2011
- Experience With Lacosamide in a Series of Children With Drug-Resistant Focal EpilepsyPediatric Neurology, 2011
- Efficacy and tolerability of oral lacosamide as adjunctive therapy in pediatric patients with pharmacoresistant focal epilepsyEpilepsy & Behavior, 2011
- Does lacosamide aggravate Lennox–Gastaut syndrome? Report on three consecutive casesEpilepsy & Behavior, 2010
- Lacosamide as adjunctive therapy for partial‐onset seizures: A randomized controlled trialEpilepsia, 2010
- Lacosamide: A Review of Preclinical PropertiesCNS Drug Reviews, 2007